skip to content
Primary navigation

Inhaled Corticosteroids

Drug - Inhaled Corticosteroids

November 2018

Therapeutic area - Respiratory/Asthma

Drugs

Preferred
Asmanex (twisthaler)
Flovent Diskus
Flovent HFA
Pulmicort Flexhaler
Pulmicort Respules
Qvar

Nonpreferred
Alvesco
Armonair Respiclick
Arnuity Ellipta
Asmanex HFA
Budesonide respules
QVAR Redihaler

Approval criteria for nonpreferred products

  • Patient has a diagnosis of asthma AND
  • Patient had an adequate adherent trial and failure of (or contraindication to) 3 of the preferred products. Trials must be at least two weeks in duration of continuous daily use.

Note: Failure is defined as no improvement or worsening in asthma symptoms after at least two weeks of continued daily use of the inhaled corticosteroid.

Expected side effects of any agent within the class are not considered failure. Expected side effects include: 

  • bad taste
  • dysphonia
  • oropharyngeal candidiasis
  • cough
  • sore throat

Exceptions
See Grandfathering Criteria for patient-specific exceptions.

Quantity limit

One inhaler per month

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top